Table 1 Patient demographics and baseline characteristics (TORCH study; ITT population)
From: Long-term outcomes following first short-term clinically important deterioration in COPD
CID+ population (N = 2870) | CID- population (N = 2422) | Total (N = 5292) | |
|---|---|---|---|
Age (years), mean (SD) | 64.7 (8.2) | 65.1 (8.4) | 64.9 (8.3) |
Male, n (%) | 2151 (75) | 1895 (78) | 4046 (76) |
BMI, kg/m2, mean (SD) | 25.3 (5.3) | 25.5 (5.2) | 25.4 (5.2) |
Current smoker at screening, n (%) | 1277 (44) | 1072 (44) | 2349 (44) |
Post-bronchodilator % predicted FEV1, mean (SD) | 44.7 (13.8) | 44.8 (12.8) | 44.7 (13.4) |
Patients receiving ICS in the 12 months prior to the run-in period, n (%) | 1455 (51) | 1037 (43) | 2492 (47) |
Previous exacerbations, n (%) | |||
0 | 1122 (39) | 1164 (48) | 2286 (43) |
1 | 711 (25) | 617 (25) | 1328 (25) |
≥ 2 | 1037 (36) | 641 (26) | 1678 (32) |